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The Bacillus anthracis Carbosap genome, which includes the pXO1 and pXO2 plasmids, has been shown to encode the major
B. anthracis virulence factors, yet this strain’s attenuation has not yet been explained. Here we report the draft genome sequence
of this strain, and a comparison to fully virulent B. anthracis.
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Bacillus anthracis is a Gram-positive, spore-forming, filamen-tous bacillus and is the causative agent of anthrax in both
animals and humans (1). B. anthracis strains attenuated for viru-
lence in animals that were described in the latter part of the 19th
century, and in particular, those put forward by Pasteur, soon
came into use for vaccination against anthrax in cattle and sheep
(2).
Many attenuated strains of B. anthracis lack one of the two
virulence-associated plasmids pXO1 and pXO2. The Sterne-type
strains lack pXO2 and are toxigenic but cannot produce a capsule,
while the Pasteur-type vaccine strains lack the pXO1 plasmid and
are therefore encapsulated but nontoxigenic. Less commonly,
other strains have been shown to be attenuated despite retaining
both the pXO1 and pXO2 plasmids, which would normally result
in full virulence (3, 4).
One example of such a strain is B. anthracis Carbosap, used in
Italy as a live spore vaccine for cattle and sheep (5). The Carbosap
genome has been previously shown to contain sequences that in-
dicate the presence of pXO1 and pXO2 as well as a limited set of
chromosomal markers associated with virulence, and yet it shows
significant attenuation of virulence in rabbits (5, 6, 7).
In order to define the differences between Carbosap and other
strains of B. anthracis that may explain its attenuation, we se-
quenced the genome of Carbosap. Genomic DNA was prepared
from the Carbosap strain of B. anthracis (obtained from A.
Fasanella) using standard methods (8) and sequenced using the
454 and Illumina MiSeq platforms. A total of 344,312 454 reads
and 1,719,544 Illumina reads, totaling 390 Mb, were assembled
using Newbler version 2.7 in both de novo and reference modes,
using B. anthracis strain Ames Ancestor as a reference (9). Contigs
from the de novo assembly that showed structural variation with
respect to the reference were combined with the reference assem-
bly using Minimus 2 (part of AMOS 3.1.0) to produce a draft
genome of 5,402,970 bp and 21 contigs.
Whole-genome single-nucleotide polymorphism (SNP) anal-
ysis showed that the Carbosap strain is a member of the trans-
Eurasian clade of B. anthracis; the genome also contains 3 chro-
mosomal deletions of 29, 24, and 3.5 kb relative to virulent strains
of B. anthracis, consistent with previous array and PCR analyses
(10). There were no major changes found in the Carbosap pXO1
and pXO2 sequences relative to plasmids from the Ames Ancestor
strain. The chromosomal deletions contain 50 annotated genes,
many of which have a known or proposed function that could be
linked to virulence, so the precise nature of Carbosap’s attenua-
tion remains unclear. A similar situation was recently reported for
the B. anthracis CDC 684 strain (11), and it seems likely that in
both cases further investigation into the functional effects of the
genomic changes in these two strains will yield new insights into
B. anthracis pathogenesis and aid in the identification of potential
targets for development of new anthrax therapeutics.
Nucleotide sequence accession number. This Whole Genome
Shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession no. ANAO00000000. The version described in
this paper is the first version.
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